"GLP-1 and muscle loss" is one of the most searched concerns among patients considering GLP-1 therapy, and the clinical evidence supports the concern
Current evidence does not support permanent hair follicle damage from these medications
The treatment isn't magic, but it does what it's designed to do when paired with realistic expectations and a healthy lifestyle
The product type segment includes semaglutide, liraglutide, exenatide, dulaglutide, and others, with semaglutide leading the market in 2024, accounting for 58.4% of total share
Insurance & Payment Information Our medical weight loss programs are self-pay only
Emphasizing nutrient-dense carbohydrates, lean proteins, and unsaturated fats supports metabolic efficiency and training adaptation